Immunovant (NASDAQ:IMVT) reported its Q3 earnings results on Friday, February 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Immunovant missed estimated earnings by 9.09%, reporting an EPS of $-0.36 versus an estimate of $-0.33, which did not surprise analysts.
Also check this: Executives Buy More Than $28M Of 4 Stocks
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05, which was followed by a 1.61% drop in the share price the next day.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
